Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05176288
Title Avelumab, Palbociclib and Axitinib in Advanced RCC (APART)
Acronym APART
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bradley A. McGregor
Age Groups: adult | senior
Covered Countries

No variant requirements are available.